Delivery Order SPE2DB20D1004-SPE2DB22FG2L2

Award Date 9/27/22
Potential Completion Date 9/28/22
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,059.39 Firm Fixed Price Delivery Order is for the supply of 4,555,709,985 units of the pharmaceutical product Chlorthalidone 25 mg Tablets. The contract has an ultimate completion date of December 15, 2021 and was awarded on December 14, 2021. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency's (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The contract is for the delivery of 4,562,259,626 units of the drug Chlorthalidone 25 mg tablets to support military healthcare programs. The award has a 1-year period of performance ending on September 8, 2023, with a ceiling value of $20,184.05. The...
This federal contract award is for the delivery of 4,564,465,708 chlorthalidone 25 mg tablets (1,000s) to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 1, 2024, with a completion date of May 2, 2024. The contract type is a Delivery Order with a Firm Fixed Price of $2,791.12. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorthalidone 25 mg tablets. The $3,417.69 Firm Fixed Price contract has a completion date of May 11, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,808.37 firm fixed-price delivery order is for the supply of 4,560,651,696 units of the medication chlorthalidone 25 mg tablets. The contract has an ultimate completion date of April 20, 2023. This award is a task order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,862,399 units of the pharmaceutical product Chlorthalidone 25 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,568.59, with a period of performance through September 19, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will be providing these essential medication supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorthalidone 25 mg tablets. The $18,967.65 firm-fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical...
This federal contract award is for the supply of Chlorthalidone 25 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,323.61, and has an ultimate completion date of June 16, 2023. The contract does not...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,674.50 contract is for the delivery of Chlorthalidone 25 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,579.16, is for the delivery of 4558370948 CHLORTHALIDONE 25 MG TABLET 100S. It is a Firm Fixed Price Delivery Order with a completion date of September 8, 2022. The contract was awarded on September 7, 2022 and does not have a set-aside designation, indicating open...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FG2L2
    Delivery Order

This federal contract award, valued at $1,107.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,558,614,232 chlorthalidone 25 mg tablets in quantities of 100s, with a completion date of September 28, 2022.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:45 AM